| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |